Research On Financial Fraud And Preventive Measures Of Pharmaceutical Enterprises From The Perspective Of Fraud Triangular Theory

With the convening of the 19 th National Congress,healthy China has become an important development strategy,and China’s pharmaceutical industry has also made great progress.Under the influence of the epidemic,China has increased investment in the medical industry,with the aging of the population age structure and the increase of user consumption,the pharmaceutical industry has opened up new development opportunities,but we cannot ignore the fact that the financial fraud cases of listed companies in the pharmaceutical industry have been repeatedly banned,hindering the sustainable development of the industry.Therefore,how to combine the audit characteristics of pharmaceutical enterprises,study the behavior of pharmaceutical enterprises in the field of financial fraud,and put forward effective suggestions and management measures is not only a hot spot for scientists,but also one of the concerns of investors,external regulators and enterprises themselves.This paper adopts one case analysis methodology and selects Furen Pharmaceutical,which faced financial malfeasance scandals in 2019,as a subject of research,which is a typical family business with a large amount of fraud,and adopts the "triangle fraud theory" for analysis.First,the process of fraud of the pharmaceutical company Furen was briefly explained,and the main methods of abnormal accounting data and fraud in the annual report were analyzed,and then the motivation was analyzed in detail from three aspects of "pressure,possibility and apology",taking this issue as a starting point,combined with the current situation and characteristics of the development of the Chinese pharmaceutical industry.Proposals and preventive measures related to financial fraud in pharmaceutical industry.After analysis,it is found that in recent years,a large number of related party transactions,incomplete information disclosure,"double-high deposits and loans",and incorrect presentation of R&D expenses in China’s pharmaceutical industry have often been long-term and systematic,thus constituting a unique review risk for pharmaceutical enterprises.By analyzing the basic characteristics and motives of fern financial fraud,it is concluded that the pressure of "gambling",lack of management behavior,imperfect internal control system,and negligence of third-party institutions is the main reasons for fern financial fraud.It always reminds us to take care to identify illicit transactions by interested parties when conducting financial audits and monitoring pharmaceutical establishments.Pay close attention to proof of responsibility and use of operating expenses,requirements for governments and listed pharmaceutical companies to work together to improve the oversight of offshore companies,increase legal fees for financial regulation violations,scientifically improve the process of delisting companies,increase the cost of fraud.